(Q40603608)

22 September 2017

title

The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines (English)

1 reference

22 September 2017

Robert Saeid Farivar

1

1 reference

22 September 2017

James Gardner-Thorpe

2

1 reference

22 September 2017

Hiromichi Ito

3

1 reference

22 September 2017

Hassan Arshad

4

1 reference

22 September 2017

Michael J Zinner

5

1 reference

22 September 2017

Stanley W Ashley

6

1 reference

22 September 2017

Edward E Whang

7

1 reference

22 September 2017

publication date

1 December 2003

1 reference

Journal of Surgical Research

22 September 2017

published in

1 reference

22 September 2017

volume

115

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

219-225

1 reference

Discovery of novel tumor markers of pancreatic cancer using global gene expression technology

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Differential display of expressed genes in pancreatic cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Protein tyrosine kinase inhibitors as novel therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

1001 protein kinases redux--towards 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Protein kinase inhibitors: the tyrosine-specific protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Complete molecular remission in chronic myelogenous leukemia after imatinib therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

Imatinib mesylate--a new oral targeted therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900246-4

10.1016/S0022-4804(03)00246-4

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference